Caldwell Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Caldwell Trust's BIIB Position: Q1 2026 in Review
Caldwell Trust held its Biogen (BIIB) position steady in Q1 2026 at 383 shares worth $70.2K. The position accounts for 0.01% of the portfolio, ranked #454.
Caldwell Trust first reported a position in BIIB in Q4 2019 and has held it in 26 quarters since. The position peaked at $565K in Q4 2019. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Caldwell Trust held 383 shares of Biogen worth $70.2K as of Q1 2026.
- Caldwell Trust left its Biogen share count unchanged in Q1 2026.
- Biogen made up 0.01% of Caldwell Trust's portfolio in Q1 2026, its #454 holding.
- Caldwell Trust first reported a position in Biogen in Q4 2019 and has held it in 26 quarters since.
- Caldwell Trust's Biogen position peaked at $565K in Q4 2019.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.